Saturday, October 10, 2026
Tech Beat

Stanford Researcher Samuel King to Discuss AI-Designed Virus Blueprints

Stanford bioengineer Samuel King discusses AI-designed virus blueprints, the limits of synthetic life and biology's future in an interview on October 16, 2026.

Listen to this briefingAudio briefing

Summary

Stanford University bioengineering PhD candidate Samuel King, also affiliated with Arc Institute, used a generative AI model in 2025 to propose genetic blueprints for microscopic viruses. The experiment offered a preliminary answer to whether AI can design new life forms, but it did not create AI-generated life. King has since been named an Innovators Under 35 honoree.

Announced October 9, 2026, the subscriber-only roundtable goes live Friday, October 16, at 18:30 BST, 1:30 p.m. EDT and 10:30 a.m. PDT. Senior AI reporter James O'Donnell will interview King about the virus-design work, the honor and new ways of seeing biology. Registration is open.

Positives

  • King used generative AI in 2025 to propose genetic blueprints for microscopic viruses.
  • King's work provides a preliminary demonstration that AI can contribute to designing biological structures.
  • King was named an Innovators Under 35 honoree for his bioengineering work.
  • James O'Donnell will explore the research and its implications with King on October 16.

Risks & concerns

  • King's experiment did not produce AI-generated life, leaving the central technical leap unrealized.
  • The announcement identifies no AI model, experimental protocol or biological safety measures.
  • Access to the October 16 roundtable is restricted to subscribers.
Primary sourceArtificial intelligence – MIT Technology Reviewhttps://www.technologyreview.com/2026/10/08/1146224/roundtables-a-conversation-with-the-creator-of-ai-designed-viruses/
Read full article
Editorial note: Tech Beat summarizes and analyzes third-party reporting. The source link is the authoritative article. This page does not reproduce the full source text.

More From The Wire

A DNA helix shaped as a double-edged key, representing both the medical promise and biological risk of AI-designed viruses. Artificial Intelligence and BiotechnologyAug 6

AI Genome Models Create Viable Viruses, Raising Biosecurity Questions

Artificial IntelligenceOct 9

Jev Maker TypeSafe AI Raises $870M at $7.5B Valuation

Artificial IntelligenceOct 9

AI Coding Agents Boost Code 30%, but Software Output Stalls